NPI registry status
Active
2026 NPPES data Interventional Pain Medicine Physician NPI 1992744312 M.D.
Verify on CMS → Thomas Ragukonis, M.D.
Interventional Pain Medicine Physician in Paramus, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,603 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
539
Medicare Part D claims · 92 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$864.51
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Thomas Ragukonis, M.D. filed 539 Medicare Part D claims in 2024 as an Interventional Pain Medicine Physician in Paramus, New Jersey, prescribing 87% generic.
- 539
- Part D claims, 2024
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Thomas Ragukonis, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1992744312), first enumerated 06/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 539 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$864.51 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1992744312 · Interventional Pain Medicine Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1992744312
- ENUM-LEGACY 2006
- TAX-NARROW 1,603
- RX-LIGHT 539
- BOOK-THIN 66 in New Jersey
- PHOTO-ENUM Akram Abdoue · 2006
Thomas Ragukonis, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
539 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Thomas Ragukonis, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Thomas Ragukonis, M.D.?
Quality data not reportedPrimary specialty
Interventional Pain Medicine Physician
Medicare Part D claims
539 76% vs specialty avg
Specialty distribution in New Jersey
How Interventional Pain Medicine Physician compares to other specialties among New Jersey providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Interventional Pain Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1992744312 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/05/2006 |
Hospital and facility affiliations
Facilities where Thomas Ragukonis, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Integrated Medical Care LLC
Paramus, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Thomas Ragukonis, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$865
Largest payer
Johnson & Johnson Health Care Systems Inc.
Most common payment type
Debt forgiveness
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Thomas Ragukonis, M.D. - brand share 13.0%
Interventional Pain Medicine Physician average
13% brand-name claims vs 87% generic, on 539 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
539
Total Claims
$29K
Total Drug Cost
92
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 545.533
- Total Day Supply
- 11,358
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $25K
- Generic Drug Cost
- $4K
- Opioid Claims
- 218 (40.4% rate)
- Antibiotic Claims
- 36
Patient Demographics
- Average Patient Age
- 68.8 years
- Avg HCC Risk Score
- 1.24
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 25, 65-74: 37, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Thomas Ragukonis, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Cyclobenzaprine Hcl
Cyclobenzaprine Hcl
76 claims
- Oxycodone Hcl
Oxycodone Hcl
76 claims
- Naproxen
Naproxen
62 claims
- Oxycontin
Oxycontin
62 claims
- Gabapentin
Gabapentin
49 claims
- Tramadol Hcl
Tramadol Hcl
33 claims
- Oxycodone-Acetamin… 27
Oxycodone-Acetaminophen
27 claims
- Cephalexin 24
Cephalexin
24 claims
| Drug | Claims |
|---|---|
| Cyclobenzaprine Hcl | 76 |
| Oxycodone Hcl | 76 |
| Naproxen | 62 |
| Oxycontin Oxycodone Hcl | 62 |
| Gabapentin | 49 |
| Tramadol Hcl | 33 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 27 |
| Cephalexin | 24 |
| Baclofen | 19 |
| Celecoxib | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Interventional Pain Medicine Physician in NJ →
All providers in New Jersey →
Compare specialties →
Interventional Pain Medicine Physician Overview
How Thomas Ragukonis, M.D. fits within the Interventional Pain Medicine Physician landscape nationally.
1,603
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,221
Avg Claims per Provider
Thomas Ragukonis, M.D.'s 539 claims are below the specialty average of 2,221.
Nationwide Interventional Pain Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ragukonis, both outside New Jersey so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Interventional Pain Medicine Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Ragukonis.
One of 66 Interventional Pain Medicine Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Mrinal Agrawal
MD
Freehold, NJ
Dr. Tarek Almaleh
DO
Ridgewood, NJ
Dr. Rae Aranas
M.D.
Bridgewater, NJ
Dr. Sumeet Arora
D.O.
Clifton, NJ
Dr. Malaka Badri
D.O
North Bergen, NJ
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Thomas Ragukonis, M.D.'s specialty? ▼
Thomas Ragukonis, M.D. specializes in Interventional Pain Medicine Physician and practices in Paramus, New Jersey. Credentials: M.D..
How much does Thomas Ragukonis, M.D. prescribe under Medicare Part D? ▼
In 2024, Thomas Ragukonis, M.D. wrote 539 Medicare Part D claims totaling $29K in drug costs for 92 beneficiaries.
Where is Thomas Ragukonis, M.D. located? ▼
Thomas Ragukonis, M.D. is located at 37 W CENTURY RD, Paramus, NJ, 07652. Phone: (201) 634-9000.
What is Thomas Ragukonis, M.D.'s NPI number? ▼
Thomas Ragukonis, M.D.'s National Provider Identifier (NPI) is 1992744312, issued on 06/05/2006.
Does Thomas Ragukonis, M.D. prescribe more brand-name or generic drugs? ▼
Thomas Ragukonis, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $25K in brand drug costs.
Does Thomas Ragukonis, M.D. prescribe opioids? ▼
Yes, Thomas Ragukonis, M.D. had 218 opioid claims in 2024 with an opioid prescribing rate of 40.4%.
How many Interventional Pain Medicine Physician providers are there in the US? ▼
There are 1,603 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,221 Medicare Part D claims per year.
What drugs does Thomas Ragukonis, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Thomas Ragukonis, M.D.'s most frequently prescribed drugs include Cyclobenzaprine Hcl, Oxycodone Hcl, Naproxen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Thomas Ragukonis, M.D. accept Medicare? ▼
Thomas Ragukonis, M.D. appears in CMS Medicare data with 539 Part D claims and 92 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Thomas Ragukonis, M.D.'s credentials? ▼
Thomas Ragukonis, M.D.'s NPI is 1992744312 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.